HK1205767A1 - Screening, diagnosis and prognosis of autism and other developmental disorders - Google Patents
Screening, diagnosis and prognosis of autism and other developmental disordersInfo
- Publication number
- HK1205767A1 HK1205767A1 HK15106400.4A HK15106400A HK1205767A1 HK 1205767 A1 HK1205767 A1 HK 1205767A1 HK 15106400 A HK15106400 A HK 15106400A HK 1205767 A1 HK1205767 A1 HK 1205767A1
- Authority
- HK
- Hong Kong
- Prior art keywords
- autism
- prognosis
- diagnosis
- screening
- developmental disorders
- Prior art date
Links
Classifications
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
- G16B25/00—ICT specially adapted for hybridisation; ICT specially adapted for gene or protein expression
- G16B25/10—Gene or protein expression profiling; Expression-ratio estimation or normalisation
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
- G16B25/00—ICT specially adapted for hybridisation; ICT specially adapted for gene or protein expression
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
- G16H50/00—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics
- G16H50/20—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics for computer-aided diagnosis, e.g. based on medical expert systems
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/118—Prognosis of disease development
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/158—Expression markers
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/28—Neurological disorders
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Genetics & Genomics (AREA)
- Physics & Mathematics (AREA)
- General Health & Medical Sciences (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Molecular Biology (AREA)
- Organic Chemistry (AREA)
- Medical Informatics (AREA)
- Biotechnology (AREA)
- Biophysics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Analytical Chemistry (AREA)
- Pathology (AREA)
- Biomedical Technology (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Immunology (AREA)
- Spectroscopy & Molecular Physics (AREA)
- Theoretical Computer Science (AREA)
- Bioinformatics & Computational Biology (AREA)
- Evolutionary Biology (AREA)
- Public Health (AREA)
- Biochemistry (AREA)
- Microbiology (AREA)
- General Engineering & Computer Science (AREA)
- Data Mining & Analysis (AREA)
- Primary Health Care (AREA)
- Epidemiology (AREA)
- Databases & Information Systems (AREA)
- Urology & Nephrology (AREA)
- Hematology (AREA)
- General Physics & Mathematics (AREA)
- Medicinal Chemistry (AREA)
- Food Science & Technology (AREA)
- Cell Biology (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201261675928P | 2012-07-26 | 2012-07-26 | |
| PCT/US2013/052094 WO2014018774A1 (fr) | 2012-07-26 | 2013-07-25 | Dépistage, diagnostic et pronostic de l'autisme et autres troubles du développement |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| HK1205767A1 true HK1205767A1 (en) | 2015-12-24 |
Family
ID=49997839
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HK15106400.4A HK1205767A1 (en) | 2012-07-26 | 2015-07-06 | Screening, diagnosis and prognosis of autism and other developmental disorders |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US10002230B2 (fr) |
| EP (1) | EP2877605A4 (fr) |
| CN (1) | CN104662173A (fr) |
| AU (1) | AU2013295732A1 (fr) |
| BR (1) | BR112015001642A2 (fr) |
| CA (1) | CA2879359A1 (fr) |
| EA (1) | EA201590175A1 (fr) |
| HK (1) | HK1205767A1 (fr) |
| MX (1) | MX2015001068A (fr) |
| WO (1) | WO2014018774A1 (fr) |
Families Citing this family (37)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US10039777B2 (en) | 2012-03-20 | 2018-08-07 | Neuro-Lm Sas | Methods and pharmaceutical compositions of the treatment of autistic syndrome disorders |
| US10560469B2 (en) * | 2014-01-24 | 2020-02-11 | Hewlett Packard Enterprise Development Lp | Identifying deviations in data |
| US10255337B2 (en) * | 2015-03-31 | 2019-04-09 | Change Healthcare Holdings, Llc | Health care information system and method for transforming health care data with a transformation pipeline |
| US20180245154A1 (en) | 2015-07-01 | 2018-08-30 | Duke University | Methods to diagnose and treat acute respiratory infections |
| WO2017083310A1 (fr) * | 2015-11-09 | 2017-05-18 | Inkaryo Corporation | Procédé de normalisation pour analyse d'échantillons |
| CN105652016A (zh) * | 2016-01-28 | 2016-06-08 | 深圳大学 | 一种孤独症检测标志物及其检测方法 |
| WO2017149542A1 (fr) * | 2016-03-01 | 2017-09-08 | Sentimetrix, Inc | Système de criblage d'évaluation neuropsychologique |
| CN106381330A (zh) * | 2016-08-30 | 2017-02-08 | 张建华 | 一种检测交通性脑积水易感性的引物及试剂盒 |
| KR101887161B1 (ko) | 2016-10-10 | 2018-08-09 | 오동훈 | 자폐 스펙트럼 장애의 진단용 조성물, 이를 포함하는 마이크로어레이 및 이를 검출하는 방법 |
| US20180251849A1 (en) * | 2017-03-03 | 2018-09-06 | General Electric Company | Method for identifying expression distinguishers in biological samples |
| JP2020510049A (ja) * | 2017-03-13 | 2020-04-02 | デューク ユニバーシティ | 自閉症スペクトラム障害の処置のための方法 |
| CN107058526B (zh) * | 2017-03-21 | 2020-12-29 | 济南大学 | 一种基于基因对共表达模式动态关联解析玉米籽粒类胡萝卜素代谢调控机制的方法 |
| CN108784666B (zh) * | 2017-05-04 | 2023-01-13 | 深圳市生码医疗科技有限公司 | 连续监测心血管的精准医疗系统及数据处理方法 |
| CN107169274A (zh) * | 2017-05-05 | 2017-09-15 | 深圳市心智心理测量技术研究所有限公司 | 阿斯伯格综合症问卷处理方法、装置、设备及存储介质 |
| US10470659B2 (en) * | 2017-06-08 | 2019-11-12 | Fdna Inc. | Systems, methods, and computer-readable media for gene and genetic variant prioritization |
| WO2019099753A1 (fr) * | 2017-11-15 | 2019-05-23 | The Translational Genomics Research Institute | Tests de biomarqueurs de substitution et procédés de tests de chimie sanguine standard |
| CN110097240A (zh) * | 2018-01-30 | 2019-08-06 | 郑州大学西亚斯国际学院 | 一种基于互联网的创业潜质情景模拟测评系统及方法 |
| CN109142744A (zh) * | 2018-07-26 | 2019-01-04 | 珠海中科先进技术研究院有限公司 | 一种自闭症谱系障碍诊断试剂盒 |
| CN109872776B (zh) * | 2019-02-14 | 2023-06-09 | 辽宁省肿瘤医院 | 一种基于加权基因共表达网络分析对胃癌潜在生物标志物的筛选方法及其应用 |
| WO2020206447A2 (fr) * | 2019-04-05 | 2020-10-08 | Arizona Board Of Regents On Behalf Of Arizona State University | Diagnostic du risque maternel d'avoir un enfant avec un trouble du spectre autistique |
| CN110232974B (zh) * | 2019-04-22 | 2021-10-01 | 福建医科大学附属第一医院 | 多发性骨髓瘤综合风险评分方法 |
| US11468994B2 (en) * | 2019-06-28 | 2022-10-11 | Cerner Innovation, Inc. | Pneumonia readmission prevention |
| US11688505B2 (en) * | 2019-07-03 | 2023-06-27 | Kpn Innovations, Llc. | Methods and systems for generating a supplement instruction set using artificial intelligence |
| US11449792B2 (en) * | 2019-07-03 | 2022-09-20 | Kpn Innovations, Llc. | Methods and systems for generating a supplement instruction set using artificial intelligence |
| CN110331164B (zh) * | 2019-08-05 | 2021-04-06 | 北京大学人民医院(北京大学第二临床医学院) | Lilra3基因敲入小鼠的打靶载体和lilra3基因敲入小鼠的构建方法 |
| US11367508B2 (en) * | 2019-08-16 | 2022-06-21 | Tempus Labs, Inc. | Systems and methods for detecting cellular pathway dysregulation in cancer specimens |
| CN110840468B (zh) * | 2019-11-18 | 2022-04-22 | 深圳市铱硙医疗科技有限公司 | 自闭症风险评估方法及装置、终端设备、存储介质 |
| EP4097744A4 (fr) * | 2020-02-02 | 2023-06-21 | Cell-El Therapeutics Ltd. | Méthodes et kits pour caractériser et identifier un trouble du spectre autistique |
| KR102313457B1 (ko) * | 2020-02-27 | 2021-10-15 | 이화여자대학교 산학협력단 | 알츠하이머병 치매 특이적 유전자 nhlrc4 및 이를 이용한 알츠하이머병 치매 예측 |
| CN111723867A (zh) * | 2020-06-22 | 2020-09-29 | 山东大学 | 一种网络游戏迷恋度智能评估系统及方法 |
| WO2022051532A1 (fr) * | 2020-09-04 | 2022-03-10 | 10X Genomics, Inc. | Systèmes et procédés d'identification de liaisons de caractéristiques dans des données de caractéristiques multi-génomiques à partir de partitions unicellulaires |
| CN112837822B (zh) * | 2020-09-24 | 2023-05-02 | 广州市疾病预防控制中心(广州市卫生检验中心、广州市食品安全风险监测与评估中心、广州医科大学公共卫生研究院) | 预测covid-19患者发生轻至重度进展的标志物及试剂盒和建立方法 |
| CN112802546B (zh) * | 2020-12-29 | 2024-05-03 | 中国人民解放军军事科学院军事医学研究院 | 一种生物状态表征方法、装置、设备及存储介质 |
| CN113160986B (zh) * | 2021-04-23 | 2023-12-15 | 桥恩(北京)生物科技有限公司 | 用于预测全身炎症反应综合征发展的模型构建方法及系统 |
| CN114446476B (zh) * | 2022-01-28 | 2023-02-17 | 中南大学湘雅二医院 | 孤独症治疗效果预测模型构建方法、预测方法及装置 |
| WO2023198176A1 (fr) * | 2022-04-15 | 2023-10-19 | Xinhua Hospital Affiliated To Shanghai Jiaotong University School Of Medicine | Prédiction de la réponse de traitement au bumétanide chez un sujet souffrant d'un trouble du spectre autistique |
| CN117409855B (zh) * | 2023-10-25 | 2024-04-26 | 苏州卫生职业技术学院 | 一种肝细胞癌患者错配修复相关预后模型及其构建、验证方法和应用 |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6647341B1 (en) * | 1999-04-09 | 2003-11-11 | Whitehead Institute For Biomedical Research | Methods for classifying samples and ascertaining previously unknown classes |
| JP4938371B2 (ja) * | 2006-07-04 | 2012-05-23 | 独立行政法人理化学研究所 | 自閉症素因の検出方法 |
| US8173369B2 (en) * | 2008-05-15 | 2012-05-08 | The Regents Of The University Of California | Peripheral gene expression biomarkers for autism |
| EP2443259A4 (fr) * | 2009-06-16 | 2012-10-10 | Univ Columbia | Biomarqueurs associés à l'autisme et utilisations de ces derniers |
| US20130012403A1 (en) * | 2009-12-23 | 2013-01-10 | George Washington University | Compositions and Methods for Identifying Autism Spectrum Disorders |
| AU2011223789A1 (en) * | 2010-03-01 | 2012-09-20 | Caris Life Sciences Switzerland Holdings Gmbh | Biomarkers for theranostics |
| WO2011112961A1 (fr) * | 2010-03-12 | 2011-09-15 | Children's Medical Center Corporation | Procédés et compositions pour la caractérisation du trouble de spectre autistique sur la base de motifs d'expression génique |
| EP2385134A1 (fr) * | 2010-05-07 | 2011-11-09 | Ludwig-Maximilians-Universität München | Procédé de pronostic de risque pour leucémie lymphocyte chronique |
-
2013
- 2013-07-25 CA CA2879359A patent/CA2879359A1/fr not_active Abandoned
- 2013-07-25 BR BR112015001642A patent/BR112015001642A2/pt not_active IP Right Cessation
- 2013-07-25 EA EA201590175A patent/EA201590175A1/ru unknown
- 2013-07-25 AU AU2013295732A patent/AU2013295732A1/en not_active Abandoned
- 2013-07-25 CN CN201380049845.3A patent/CN104662173A/zh active Pending
- 2013-07-25 EP EP13823113.9A patent/EP2877605A4/fr not_active Withdrawn
- 2013-07-25 WO PCT/US2013/052094 patent/WO2014018774A1/fr active Application Filing
- 2013-07-25 MX MX2015001068A patent/MX2015001068A/es unknown
-
2015
- 2015-01-26 US US14/604,834 patent/US10002230B2/en active Active
- 2015-07-06 HK HK15106400.4A patent/HK1205767A1/xx unknown
Also Published As
| Publication number | Publication date |
|---|---|
| WO2014018774A1 (fr) | 2014-01-30 |
| US20150227681A1 (en) | 2015-08-13 |
| AU2013295732A1 (en) | 2015-02-05 |
| EP2877605A4 (fr) | 2016-03-02 |
| MX2015001068A (es) | 2015-04-08 |
| CN104662173A (zh) | 2015-05-27 |
| BR112015001642A2 (pt) | 2017-07-04 |
| CA2879359A1 (fr) | 2014-01-30 |
| EP2877605A1 (fr) | 2015-06-03 |
| US10002230B2 (en) | 2018-06-19 |
| EA201590175A1 (ru) | 2015-06-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HK1205767A1 (en) | Screening, diagnosis and prognosis of autism and other developmental disorders | |
| IL244457B (en) | Automatic filtering of enzyme variants | |
| HK1202672A1 (en) | Diagnostic processes that factor experimental conditions | |
| IL239262A0 (en) | Scanning methods | |
| EP2854514A4 (fr) | Sélection de symbiotes en criblant plusieurs associations hôte-symbiote | |
| GB201321559D0 (en) | Diagnosis of the condition of apparatus | |
| EP2724329A4 (fr) | Système d'alerte basé sur les données relatives à la consommation de ressources | |
| EP2826473A4 (fr) | Nouvelle utilisation du patchoulol | |
| PL2836305T3 (pl) | Zespół filtrujący | |
| GB201211982D0 (en) | Biomarker | |
| EP2834638A4 (fr) | Procédés et compositions de diagnostic et de pronostic d'un sepsis | |
| EP2888370A4 (fr) | Méthodes diagnostiques, pronostiques et méthodes de traitement | |
| AP2013007271A0 (en) | Point-of-care, medical condition screening kit | |
| GB2508667B (en) | Diagnosis of the condition of apparatus | |
| EP2841942A4 (fr) | Méthodes de dépistage d'une pré-éclampsie | |
| GB201206382D0 (en) | Parkinson's disease biomarker | |
| EP2917731A4 (fr) | Protocoles diagnostiques, pronostiques, thérapeutiques et de criblage | |
| EP2875347A4 (fr) | Procédés et compositions pour le diagnostic et le pronostic de la sepsie | |
| EP2924124A4 (fr) | Méthode de diagnostic et/ou de pronostic de maladies neurodégénératives | |
| GB2499728B (en) | Sewage screening system | |
| GB201209802D0 (en) | Biomarker | |
| GB201202944D0 (en) | Biomarker | |
| GB201216122D0 (en) | Screening assay | |
| GB201213770D0 (en) | Screening methods | |
| EP2704800A4 (fr) | Procédé de prédiction du développement d'une maladie à médiation par le complément |